​

Funding Round

Series A - Rubedo Life Sciences

Series A - Rubedo Life Sciences

Investment Firm

Overview

Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.

Announced Date

Apr 22, 2024

Closed on Date

Apr 22, 2024

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Khosla Ventures

Khosla Ventures

Khosla Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

9

Investor Name
Participant InvestorHevolution
Participant InvestorShanda Group
Participant InvestorItalian Angels for Growth
Participant InvestorRefactor
Participant InvestorKhosla Ventures

Round Details and Background

Rubedo Life Sciences raised $40000000 on 2024-04-22 in Series A

Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 03, 2020
Seed Round - Rubedo Life Sciences
4-12.0M
Dec 01, 2021
Series A - Rubedo Life Sciences
-undefined
Feb 06, 2023
Grant - Rubedo Life Sciences
1-1.4M
Apr 22, 2024
Series A - Rubedo Life Sciences
11-40.0M

Recent Activity

There is no recent news or activity for this profile.